Effects of ErbB2 Overexpression on the Proteome and ErbB Ligand-specific Phosphosignaling in Mammary Luminal Epithelial Cells

Most breast cancers arise from luminal epithelial cells, and 25–30% of these tumors overexpress the ErbB2/HER2 receptor that correlates with disease progression and poor prognosis. The mechanisms of ErbB2 signaling and the effects of its overexpression are not fully understood. Herein, stable isotop...

Descripción completa

Detalles Bibliográficos
Autores principales: Worthington, Jenny, Spain, Georgia, Timms, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383782/
https://www.ncbi.nlm.nih.gov/pubmed/28174229
http://dx.doi.org/10.1074/mcp.M116.061267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383782/
https://www.ncbi.nlm.nih.gov/pubmed/28174229
http://dx.doi.org/10.1074/mcp.M116.061267

Ejemplares similares